Specific rescue of cystic fibrosis transmembrane conductance regulator processing mutants using pharmacological chaperones

Molecular Pharmacology
Ying WangD M Clarke

Abstract

Most mutants of the cystic fibrosis transmembrane conductance regulator (CFTR) that cause severe symptoms of cystic fibrosis do not reach the cell surface because they are defective in folding. Many CFTR folding mutants, however, including the DeltaF508 mutant found in more than 90% of cystic fibrosis patients, are potentially functional at the cell surface if they can be induced to fold correctly. In a previous study (Mol Pharm 2:407-413, 2005), we reported that a quinazoline derivative (CFcor-325) could rescue CFTR processing mutants. The corrector was not specific however, as it could also rescue a processing mutant of CFTR's sister protein, the multidrug resistance P-glycoprotein. The goal of this study was to test whether it was possible to specifically rescue CFTR processing mutants using a pharmacological chaperone. In this article, we report that two compounds, 4-methyl-2-(5-phenyl-1H-pyrazol-3-yl)-phenol (CFpot-532) and 2-phenylamino-4-(4-ethylene-phenyl)-thiazole (corr-2b) could rescue CFTR processing mutants such as DeltaF508 CFTR but not a P-glycoprotein processing mutant. The compound CFpot-532 also acts as a potentiator of DeltaF508 CFTR channel activity. Therefore, the results suggest that the mechanism whereby C...Continue Reading

References

Sep 15, 1995·The Journal of Biological Chemistry·T W Loo, D M Clarke
Jan 12, 1996·The Journal of Biological Chemistry·S SatoR R Kopito
Jan 10, 1997·The Journal of Biological Chemistry·T W Loo, D M Clarke
Oct 3, 1999·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·T W Loo, D M Clarke
Oct 9, 2003·The Journal of Biological Chemistry·Xue-Mei ZhangSandra E Guggino
May 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·Estelle Cormet-BoyakaKevin L Kirk
Nov 9, 2004·Biochemical and Biophysical Research Communications·Tip W LooDavid M Clarke
Aug 30, 2005·The Journal of Clinical Investigation·Nicoletta PedemonteA S Verkman
Oct 4, 2005·Molecular Pharmaceutics·Tip W LooDavid M Clarke
Jan 31, 2006·American Journal of Physiology. Lung Cellular and Molecular Physiology·Fredrick Van GoorPaul Negulescu
Feb 4, 2006·The Journal of Membrane Biology·T W Loo, D M Clarke
May 13, 2006·Journal of Bioenergetics and Biomembranes·Tip W LooDavid M Clarke

❮ Previous
Next ❯

Citations

Sep 17, 2010·The Journal of Biological Chemistry·Raymond J LouieElizabeth A Miller
Jul 25, 2009·Molecular Biology of the Cell·Diane E GroveDouglas M Cyr
Dec 25, 2009·Molecular Biology of the Cell·Gargi RoyXiaodong Wang
Jun 7, 2011·American Journal of Physiology. Lung Cellular and Molecular Physiology·Ray A CaldwellDouglas M Cyr
Jul 5, 2011·American Journal of Physiology. Lung Cellular and Molecular Physiology·Louise C PyleSteven M Rowe
Jun 9, 2009·American Journal of Respiratory Cell and Molecular Biology·Asta JurkuvenaiteJames F Collawn
Dec 6, 2007·BMC Biochemistry·Emma L TurnbullDouglas M Cyr
Oct 27, 2010·Journal of Computer-aided Molecular Design·Ori KalidHanoch Senderowitz
Feb 6, 2013·Trends in Pharmacological Sciences·John W HanrahanDavid Y Thomas
Feb 15, 2018·Physiological Reviews·Ya-Xiong Tao, P Michael Conn
Jan 31, 2008·The Journal of Pharmacology and Experimental Therapeutics·Caroline NorezFrédéric Becq
May 13, 2014·American Journal of Physiology. Lung Cellular and Molecular Physiology·Maria FaviaValeria Casavola
Jun 29, 2007·Expert Reviews in Molecular Medicine·Tip W Loo, David M Clarke
Sep 24, 2009·Pediatric Pulmonology·Himabindu PenmatsaAnjaparavanda P Naren
May 28, 2011·Journal of Cellular Physiology·Monica CattaneoIda Biunno
Jul 15, 2015·Pharmacology Research & Perspectives·Carlos M FarinhaMargarida D Amaral
Aug 27, 2016·Expert Opinion on Drug Delivery·Neeraj Vij
Jun 12, 2014·Human Mutation·Sampath K Loganathan, Joseph R Casey
Jun 3, 2008·American Journal of Physiology. Lung Cellular and Molecular Physiology·Caroline NorezMarco Colombatti
Sep 30, 2015·The FEBS Journal·Carlos M Farinha, Paulo Matos
Aug 10, 2012·American Journal of Physiology. Renal Physiology·Hongyu LiDavid N Sheppard
Mar 26, 2008·The Biochemical Journal·Tip W LooDavid M Clarke
May 13, 2020·Biomolecules·Karina Juarez-NavarroAngelica Lopez-Rodriguez
Jun 15, 2007·The Journal of Biological Chemistry·Nadezhda S SabevaGregory A Graf
Sep 12, 2015·American Journal of Rhinology & Allergy·Jennifer L WentzelZachary M Soler
Mar 14, 2007·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Gerd DöringUNKNOWN Consensus Study Group
Aug 5, 2017·Chemical Reviews·George M Burslem, Craig M Crews
Jun 19, 2007·Trends in Pharmacological Sciences·Margarida D Amaral, Karl Kunzelmann

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.